An ELISA for quantification of murine IgG in rat plasma: Application to the pharmacokinetic characterization of AP-3, a murine anti-glycoprotein IIIa monoclonal antibody, in the rat

Journal of Pharmaceutical and Biomedical Analysis

Volumn 21, Issue 5, 1999, Pages 1011-1016

  Hansen, Ryan J ^a   Balthasar, Joseph P ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

AP 3; ELISA; GPIIIa; IgG; Murine; Pharmacokinetics; Rat plasma; Validation

Indexed keywords

GLYCOPROTEIN IIIA; MONOCLONAL ANTIBODY;

ACCURACY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTEGRIN BETA3; MICE; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032692911     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(99)00227-7     Document Type: Article

References (17)

1. Newland A.C., Macey M.G. Ann. Hematol. 69(2):1994;61-67.
2. Fujisawa K., TE O.T., Tani P., Loftus J.C., Plow E.F., Ginsberg M.H., McMillan R. Blood. 77(10):1991;2207-2213.
3. Tarantino M.D., Goldsmith G. Semin. Hematol. 35(Suppl. 1):1998;28-35.
4. Imbach P., d'Apuzzo V., Hirt A., Rossi E., Vest M., Barandun S., Baumgartner C., Morell A., Schoni M., Wagner H.P. Lancet. 1:1981;228-231.
5. Newland A.C. Br. J. Haematol. 72(3):1989;301-305.
6. Imbach P.A. Clin. Exp. Immunol. 97(Suppl 1):1994;25-30.
7. Hou M., Stockelberg D., Kutti J., Wadenvik H. Br. J. Haematol. 98(1):1997;64-67.
8. Newman P.J., Allen R.W., Kahn R.A., Kunicki T.J. Blood. 65(1):1985;227-232.
9. Bazin Redureau M.I., Renard C.B., Scherrmann J.M. J. Pharm. Pharmacol. 49(3):1997;277-281.
10. Barrett J.S., Wagner J.G., Fisher S.J., Wahl R.L. Cancer Res. 51(13):1991;3434-3444.
11. Fleming J.O., Pen L.B. J. Immunol. Methods. 110(1):1988;11-18.
12. Klein Schneegans A.S., Kuntz L., Fonteneau P., Loor F. J. Immunol. Methods. 125(1-2):1989;207-213.
13. Hellstrom K.E., Yelton D.E., Fell H.P., Beaton D., Gayle M., MacLean M., Kahn M., Hellstrom I. Cancer Res. 50(8):1990;2449-2454.
14. Caballero F., Pelegri C., Castell M., Franch A., Castellote C. Immunopharmacology. 39(2):1998;83-91.
15. C. Pelegri, M. Paz Morante, C. Castellote, M. Castell, A. Franch, Cell. Immunol. 165 (2) (1995) 177-182.
16. Klein Schneegans A.S., Gaveriaux C., Fonteneau P., Loor F. J. Immunol. Methods. 119(1):1989;117-125.
17. al Bander H.A., Martin V.I., Kaysen G.A. Am. J. Physiol. 262(3):1992;F333-337.